F33, Clinical independent clinical F37, Trial Not Duration trials. 1.4a F38, Allowed FI2, FOAs 1.4d are ALL Incl New K’s: Rule October K05, 2017 K07, Release K08, K18, K22, K23, K26, N N NIH, 1.0 Excl: Both E Study PHS Section 034.8.26 Provide error for For study titled Record Human a Clinical Trial <study title>, A – K12 fields in Subject Study if response to the Sections and response to the question the “Will IV and V Clinical question, study use an FDA “Will – = are “R" Trial the study use an regulated or required FDA regulated is "O") – intervention?” for 4.6 Will AND intervention? is required since you studies involving the not provided. answered to “Yes” study questions 1.4.a-1.4.d to use an clinical FDA –
Excl: Duration 1.4a 1.4d are ALL F33, F37, F38, FI2, Incl K’s: K05, K07, K08, K18, K22, K23, K26, independent clinical trials. Clinical Trial Not Allowed FOAs New Rule October 2017 Release PHS Human Subject and Clinical Trial Section – 4.6 Will the study use an FDA – 034.8.26 N N NIH, 1.0 = “R" or "O") AND to K12 Both Provide error for a Clinical Trial Study if response to the question, “Will the study use an FDA – regulated intervention? is not provided. For study titled <study title>, A response to the question “Will the study use an FDA – regulated intervention?” is required since you answered “Yes” to questions 1.4.a-1.4.d E Study Record fields in Sections IV and V are required for studies involving clinical
eSub-validations-draft-09-12-2017.docx